M. McCoy

Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation

M. McCoy, J. Gesell, M. Senior, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.

M. McCoy, M. Senior, D. Wyss, 2004, Journal of medicinal chemistry.

Screening of protein kinases by ATP-STD NMR spectroscopy.

M. McCoy, M. Senior, D. Wyss, 2005, Journal of the American Chemical Society.

Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations.

M. McCoy, D. Wyss, Daniel F Wyss, 2002, Journal of the American Chemical Society.

Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.

M. McCoy, D. Wyss, Charles E Whitehurst, 2011, ACS medicinal chemistry letters.

Evaluation of kinetic models for biospecific adsorption and its implications for finite bath and column performance

A. Liapis, M. McCoy, M. Mccoy, 1991 .

Perfusion chromatography: Effect of micropore diffusion on column performance in systems utilizing perfusive adsorbent particles with a bidisperse porous structure

A. Liapis, M. McCoy, M. Mccoy, 1994 .

NMR Binding and Functional Assays for Detecting Inhibitors of S. aureus MnaA

M. McCoy, D. Wyss, T. Roemer, 2016, Journal of biomolecular screening.

Characterization of large-pore polymeric supports for use in perfusion biochromatography.

M. McCoy, N. Afeyan, N. Gordon, 1998, Journal of chromatography. A.

Identification of preferred multimodal ligand‐binding regions on IgG1 FC using nuclear magnetic resonance and molecular dynamics simulations

Camille L. Bilodeau, S. Cramer, M. McCoy, 2020, Biotechnology and bioengineering.